International regulators discuss available knowledge supporting COVID-19 medicine development

This second workshop of the International Coalition of Medicines Regulatory Authorities saw discussion of availability of potential treatments for COVID-19, including progress on medicine development, ongoing and planned clinical trials, and compassionate and off-label use.

European Medicines Agency